Epigenetically Active Drugs Inhibiting DNA Methylation and Histone Deacetylation

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|23|8|1167-1174

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.23, Iss.8, 2017-04, pp. : 1167-1174

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Histone Deacetylation and Motor Neuron Degeneration

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 3, 2010-07 ,pp. : 279-284

Bentham Science Publishers

Access to resources Recommend Favorite

Glucocorticoid-mediated transrepression is regulated by histone acetylation and DNA methylation

By Kagoshima M.   Wilcke T.   Ito K.   Tsaprouni L.   Barnes P.J.   Punchard N.   Adcock I.M.  

European Journal of Pharmacology, Vol. 429, Iss. 1, 2001-10 ,pp. : 327-334

Elsevier

Access to resources Recommend Favorite

Choline Nutrition Programs Brain Development Via DNA and Histone Methylation

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 12, Iss. 2, 2012-06 ,pp. : 82-94

Bentham Science Publishers

Access to resources Recommend Favorite

Epigenetic Therapy: Histone Acetylation, DNA Methylation and Anti-Cancer Drug Discovery

By  

Current Cancer Drug Targets, Vol. 9, Iss. 8, 2009-12 ,pp. : 963-981

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacological Histone Deacetylation Distinguishes Transcriptional Regulators

By  

Current Topics in Medicinal Chemistry, Vol. 17, Iss. 14, 2017-04 ,pp. : 1611-1622

Bentham Science Publishers

Access to resources Recommend Favorite